Author: Christa Nuber

Oticon Marketing Conference Explores Tactics for Growth

More than 160 hearing care professionals participated in the Oticon Drive Marketing Conference, held August 12-14 in Charlotte, NC. The group explored new marketing approaches and tools to accelerate practice growth in today’s highly competitive hearing care marketplace.

Read More

NF2 Trial: An Interview with Rick Friedman, MD, PhD

Hearing Review interviewed Rick Friedman, MD, PhD, about NF2 and an NF2 clinical that is underway in Los Angeles and at 12 other sites in the US. The trial uses the chemotherapy drug Avastin (bevacizumab) as a potential therapy for shrinking NF2 tumors, or stemming their growth.

Read More